"Yesterday's announcement marks a major win for ESRD patients across the country who wish to take advantage of the reforms the Affordable Care Act promised to all Americans," said Hrant Jamgochian, Executive Director of Dialysis Patient Citizens. "By clarifying that MSP will apply equally both inside and outside of the exchanges, the Administration is ensuring equitable treatment for some of America's most vulnerable patients, while upholding the longstanding partnership between private plans and Medicare that so many ESRD patients rely on."

RIVER EDGE, N.J., Feb. 10, 2012 /PRNewswire/ -- Nephros, Inc.

An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients.

Newly published research shows that more patients with end-stage renal disease (ESRD) caused by lupus nephritis choose hemodialysis as their initial kidney replacement therapy over peritoneal dialysis and preemptive kidney transplantation.

LAWRENCE, Mass., Nov. 2, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Barry M.